Elaine D. Sun - 15 Mar 2025 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
15 Mar 2025
Net transactions value
$0
Form type
3
Filing time
19 Mar 2025, 16:25:58 UTC
Previous filing
28 May 2024
Next filing
19 Mar 2025

No securities are beneficially owned.